PrimeRFP SCOUT · Federal Contract Recompete Brief

15DDHQ26P00000194Synthesis of DRUG substances — Cayman Chemical Co. Inc

Cayman Chemical Co. Inc holds $1.7M across 26 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 3 offers. Set-aside status: NONE. PoP ended Aug 31, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Headquaters

Awarding office

Cayman Chemical Co. Inc

Recipient

Aug 31, 2026

PoP end

$230K

Obligated

$230K

Potential

325199

NAICS

6810

PSC

NONE

Set-aside

3 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Cayman Chemical Co. Inc — $90

Contract facts

NONE

Contract number15DDHQ26P00000194

AgencyHeadquaters

Awarding officeHeadquaters

Awarding agencyDepartment of Justice (DOJ)

Funding agencyDepartment of Justice (DOJ)

IncumbentCayman Chemical Co. Inc

CAGE458H9

UEIT1ZHJRGR7TF4

NAICS325199

No full NAICS 325199 intel page yet. Browse NAICS intelligence

PSC6810

Place of performanceANN ARBOR MI

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

Related solicitationD-26-DO-0004

PoP startJan 22, 2026

PoP end (current)Aug 31, 2026

Obligated$230K

Current value$230K

Potential value$230K

SYNTHESIS OF DRUG SUBSTANCES is a federal NONE award for Headquaters held by Cayman Chemical Co. Inc. Estimated value $230K ($230K obligated). Current period of performance ends Aug 31, 2026. Last award drew 3 bidders. Place of performance: ANN ARBOR MI. Related solicitation D-26-DO-0004.

Recompete timing

Public

● Past PoP end (7 days ago)

Current PoP ended Aug 31, 2026 (7 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Cayman Chemical Co. Inc — $1.7M obligated across 26 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($1.7M) · all agencies

Department of Health and Human Services (HHS)$851K · 50%Department of Justice (DOJ)$760K · 45%Department of Defense (DOD)$72K · 4%

Environmental Protection Agency (EPA)$12K · 1%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 15DDHQ26P00000194?

15DDHQ26P00000194 (Synthesis of DRUG substances) is a Headquaters award with a potential value of $230K, currently held by Cayman Chemical Co. Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 15DDHQ26P00000194?

Headquaters awarded 15DDHQ26P00000194 to Cayman Chemical Co. Inc (potential $230K).

Who is the incumbent on 15DDHQ26P00000194?

Cayman Chemical Co. Inc is the incumbent with $1.7M across 26 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2026.

When does Cayman Chemical Co. Inc’s 15DDHQ26P00000194 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 15DDHQ26P00000194 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Jan 22, 2026